This blue chip could help investors sleep well at night. ResMed, an ASX healthcare leader, is well-positioned to capitalise on the growing demand for sleep apnoea treatment and digital health ...

ResMed Inc.’s RMD growth in the fourth quarter of fiscal 2025 can be attributed to the robust performance of its Mask business. Its recovery in the Device business continues to drive overall revenue ...

(MENAFN- GetNews) Air Voel, Canada's trusted source for CPAP and sleep therapy devices, announced today that it has expanded its product inventory to now include advanced BiPAP machines designed ...

ResMed plans to sign a lease for an about 446,500-square-foot building on Collins Road in Greenwood. The company is seeking a nearly $500,000 three-year tax break from the Greenwood City Council.

When Mick Farrell’s dad, Peter, first invited him to come and work at ResMed, which makes breathing devices for sleep apnoea, he scoffed at the idea. Farrell, an ambitious 26-year-old consultant, was ...

Powered by rising margins, global growth, and confidence from management, this sleep tech stock is turning heads again. The New York Stock Exchange-listed ResMed Inc (NYSE: RMD) share price surged ...

July 31 (Reuters) - Resmed (RMD.N), opens new tab beat Wall Street estimates for fourth-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea. The company ...

Medical device company ResMed (NYSE:RMD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per share was 3% above ...

Auto-Adjusting Pressure : The ResMed AirCurve 11 VAuto BiPAP machine features an automatic adjustment function that allows the device to change pressure settings based on real-time data. This ...

KeyBanc Capital Markets maintained its Overweight rating and $274.00 price target on ResMed (NYSE:RMD) stock following industry observations. The target aligns with broader analyst expectations, with ...